TIMOTHY MERCER: Open Payments
NPI 1184668675 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,889 in 89 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $2,999 · 2025 $1,889
Food & beverage: $1,799Education: $90
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $433 |
| GlaxoSmithKline, LLC. | 16 | $301 |
| GENZYME CORPORATION | 9 | $190 |
| Electromed, Inc. | 8 | $175 |
| Viatris Specialty LLC | 8 | $147 |
| Actelion Pharmaceuticals US, Inc. | 4 | $135 |
| Verona Pharma, Inc. | 5 | $107 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $105 |
| Regeneron Healthcare Solutions, Inc. | 4 | $100 |
| Pulmonx Corporation | 2 | $79 |
Products named: DUPIXENT, AIRSUPRA, NUCALA, SMARTVEST, FASENRA, YUPELRI, OPSUMIT, Ohtuvayre.
Industry payments across NY — which companies pay providers there.
